Behavioral Pain Self-Management Intervention Effective for Chronic Pain With HIV
By Lori Solomon HealthDay Reporter
WEDNESDAY, July 24, 2024 -- A behavioral pain self-management intervention is effective for chronic pain in people living with HIV, according to a study published online July 15 in JAMA Internal Medicine.
Katie Fitzgerald Jones, Ph.D., from the VA Boston Healthcare System, and colleagues evaluated the efficacy of a behavioral pain self-management intervention called Skills to Manage Pain (STOMP) among 278 adults with HIV who experienced at least moderate chronic pain for three or more months versus enhanced usual care (EUC).
The researchers found that of the six possible one-on-one sessions, participants attended a mean of 2.9 sessions and for the six possible group sessions, participants attended a mean of 2.4 sessions. Compared to EUC, STOMP was associated with a statistically significant mean difference for the primary outcome, Brief Pain Inventory (BPI) total score (−1.25 points) immediately after the intervention. The mean difference in BPI total score remained statistically significant three months after the intervention, favoring the STOMP intervention (−0.62 points).
"The STOMP intervention also has the potential to be tailored to other highly affected groups including cancer survivors, older adults, or veterans who frequently experience chronic multisite pain," the authors write.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2025 HealthDay. All rights reserved.
Posted July 2024
Read this next
Initiation of HIV PrEP in Young Adults Rose in Recent Years
TUESDAY, June 3, 2025 -- Dispensing and initiation of HIV preexposure prophylaxis (PrEP) among young adults increased from 2016 through 2023, according to a study published online...
ACP Issues Clinical Guideline for Statin Use in Persons With HIV
THURSDAY, May 29, 2025 -- In a clinical guideline issued by the American College of Physicians and published online May 27 in the Annals of Internal Medicine, recommendations are...
Exposure to Certain HIV Drugs May Significantly Lower Risk for Alzheimer Disease
TUESDAY, May 20, 2025 -- Exposure to nucleoside reverse transcriptase inhibitors (NRTIs), which treat HIV and hepatitis B and inhibit inflammasome activation, is associated with a...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.